We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.35%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$25.5B
AUM Growth
+$1.27B
(+5.2%)
Cap. Flow
+$15.7M
Cap. Flow
% of AUM
0.06%
Top 10 Holdings %
Top 10 Hldgs %
11.03%
Holding
2,244
New
814
Increased
508
Reduced
495
Closed
411
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$371M |
| 2 |
Citigroup
C
|
+$175M |
| 3 |
US Bancorp
USB
|
+$163M |
| 4 |
Lowe's Companies
LOW
|
+$162M |
| 5 |
Meta Platforms (Facebook)
META
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$249M |
| 2 |
Goldman Sachs
GS
|
+$228M |
| 3 |
Alibaba
BABA
|
+$162M |
| 4 |
Cemex
CX
|
+$157M |
| 5 |
Halliburton
HAL
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.75% |
| 2 | Consumer Discretionary | 12.17% |
| 3 | Healthcare | 10.26% |
| 4 | Technology | 7.43% |
| 5 | Real Estate | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PVLA
1801
Palvella Therapeutics
PVLA
$2.2B
| $69K | ﹤0.01% |
+150
| New | +$64.1K |
|
1802
Teekay Tankers
TNK
$2.67B
| $68K | ﹤0.01% |
+5,275
| New | +$67.7K |
|
1803
DHT Holdings
DHT
$2.95B
| $65K | ﹤0.01% |
+16,300
| New | +$65.4K |
|
1804
Wipro
WIT
$19.8B
| $64K | ﹤0.01% |
30,235
-11,696
| -28% | -$25.6K |
|
1805
Cerus
CERS
$470M
| $62K | ﹤0.01% |
+22,800
| New | +$55.9K |
|
1806
Anavex Life Sciences
AVXL
$303M
| $61K | ﹤0.01% |
+14,616
| New | +$65K |
|
|
EGIO
1807
DELISTED
Edgio, Inc. Common Stock
EGIO
| $61K | ﹤0.01% |
+383
| New | +$53.8K |
|
1808
Goldgroup Mining Inc.
GORO
$159M
| $60K | ﹤0.01% |
+15,889
| New | +$61.9K |
|
1809
Sunrun
RUN
$2.29B
| $60K | ﹤0.01% |
+10,788
| New | +$73.5K |
|
1810
Acacia Research
ACTG
$463M
| $59K | ﹤0.01% |
12,897
+197
| +2% | +$737 |
|
|
OBE
1811
Obsidian Energy
OBE
$638M
| $59K | ﹤0.01% |
+8,088
| New | +$59.9K |
|
|
VIVS
1812
VivoSim Labs
VIVS
$1.18M
| $58K | ﹤0.01% |
+110
| New | +$58.5K |
|
|
NPTN
1813
DELISTED
NEOPHOTONICS CORP
NPTN
| $58K | ﹤0.01% |
+10,500
| New | +$70.9K |
|
1814
Kinross Gold
KGC
$30.5B
| $57K | ﹤0.01% |
+13,429
| New | +$57.4K |
|
1815
Workhorse Group
WKHS
$36.5M
| $55K | ﹤0.01% |
+7
| New | +$62.5K |
|
|
LLEX
1816
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
| $54K | ﹤0.01% |
+11,996
| New | +$50K |
|
1817
Rigel Pharmaceuticals
RIGL
$726M
| $51K | ﹤0.01% |
+2,010
| New | +$48.9K |
|
|
NE
1818
DELISTED
Noble Corporation
NE
| $51K | ﹤0.01% |
+11,174
| New | +$42K |
|
1819
Globalstar
GSAT
$10.7B
| $50K | ﹤0.01% |
+2,060
| New | +$59.6K |
|
1820
Pixelworks
PXLW
$40.5M
| $48K | ﹤0.01% |
+850
| New | +$47.9K |
|
1821
Fate Therapeutics
FATE
$290M
| $46K | ﹤0.01% |
+11,598
| New | +$39.4K |
|
1822
Harmony Gold Mining
HMY
$11.3B
| $40K | ﹤0.01% |
22,097
-27,931
| -56% | -$51.2K |
|
|
ACGN
1823
DELISTED
Aceragen Inc
ACGN
| $40K | ﹤0.01% |
+132
| New | +$34.5K |
|
|
CPRX
1824
DELISTED
Catalyst Pharmaceutical
CPRX
| $37K | ﹤0.01% |
+14,800
| New | +$40.6K |
|
|
GEN
1825
DELISTED
Genesis Healthcare, Inc.
GEN
| $35K | ﹤0.01% |
+29,930
| New | +$37.7K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, Balyasny Asset Management held 2,244 positions worth $25.5B, up 5.2% from $24.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management's Q3 2017 filing shows 814 new, 508 increased, 495 reduced and 411 closed positions. Its largest new stake was Range Resources: 5,316,064 shares worth $104M. The largest sale was Bank of America, an estimated $249M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Balyasny Asset Management's largest Q3 2017 buy was Range Resources: 5,316,064 shares worth $104M.
- Balyasny Asset Management added most to JPMorgan Chase in Q3 2017, an estimated $371M increase.
- Balyasny Asset Management's biggest Q3 2017 reduction was Bank of America, cutting an estimated $249M.
- Balyasny Asset Management fully exited Cemex in Q3 2017, selling an estimated $157M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $25.5B portfolio in Q3 2017.
- Balyasny Asset Management opened 814 new positions and closed 411 in Q3 2017.
- Balyasny Asset Management's portfolio value rose 5.2% quarter-over-quarter to $25.5B.
Based on Balyasny Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.